Insight

Daniel Chen: After a decade of immense progress for patients with cancer immunotherapy we are excited to publish a 10-year update, reflecting the complexity in the TME.

Photo from Daniel Chen/LinkedIn

Oct 14, 2023, 16:32

Daniel Chen: After a decade of immense progress for patients with cancer immunotherapy we are excited to publish a 10-year update, reflecting the complexity in the TME.

Daniel Chen, Founder of Engenuity Life Sciences, shared on LinkedIn:

“We wrote the Cancer Immunity Cycle in 2013– and the scientific framework continues to hold up to time. After a decade of immense progress for patients with cancer immunotherapy we are excited to publish a 10Y update, reflecting the complexity in the TME.

It was an enormous effort to put together- and an incredible sprint at the end to finish. A big thanks to my co-authors Ira Mellman, Tom Powles, Shannon Turley.

And Thank You to Cell Press immunity Fabiola Rivas, Allison Bruce and all the authors that contributed to this special issue of Immunity!”

For the article click here.
Source: Daniel Chen/LinkedIn

Allison Bruce cancer Cancer Immunity Cycle Cell Press Daniel Chen Fabiola Rivas immunotherapy Ira Mellman OncoDaily Oncology Shannon Turley Tom Powles tumor microenvironment

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage